Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Colin Bristow's Stock Ratings
UBS Analyst
Colin Bristow is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/17/2025
Updated: Dec 17, 2025
Overall Average Return
-6.23%
Smart Score
Overall Average Return Percentile
22nd
Number of Ratings
107
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/12/2025 | ENGN | Buy Now | enGene Holdings | $8.38 | 19.33% | $4 → $10 | Maintains | Neutral | Get Alert | |
| 11/07/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | 20.01% | $553 → $546 | Maintains | Buy | Get Alert | |
| 08/08/2025 | GILD | Buy Now | Gilead Sciences | $118.78 | -5.71% | $108 → $112 | Maintains | Neutral | Get Alert | |
| 08/05/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | 21.55% | $582 → $553 | Maintains | Buy | Get Alert | |
| 07/29/2025 | PTCT | Buy Now | PTC Therapeutics | $75.38 | 6.12% | $71 → $80 | Maintains | Buy | Get Alert | |
| 06/17/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.48 | 43.68% | $12 → $5 | Maintains | Buy | Get Alert | |
| 05/21/2025 | ALXO | Buy Now | ALX Oncology Holdings | $1.43 | -30.07% | $1.2 → $1 | Maintains | Buy | Get Alert | |
| 04/22/2025 | IMVT | Buy Now | Immunovant | $26.87 | -36.73% | $38 → $17 | Downgrade | Buy → Neutral | Get Alert | |
| 04/14/2025 | AMGN | Buy Now | Amgen | $326.54 | -2.31% | $315 → $319 | Maintains | Neutral | Get Alert | |
| 03/28/2025 | ABOS | Buy Now | Acumen Pharmaceuticals | $2.03 | 97.04% | $6 → $4 | Maintains | Buy | Get Alert | |
| 02/14/2025 | ENGN | Buy Now | enGene Holdings | $8.38 | -16.47% | $34 → $7 | Downgrade | Buy → Neutral | Get Alert | |
| 02/11/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | 28.14% | $586 → $583 | Maintains | Buy | Get Alert | |
| 02/05/2025 | PFE | Buy Now | Pfizer | $25.43 | 10.11% | $29 → $28 | Maintains | Neutral | Get Alert | |
| 01/27/2025 | ALXO | Buy Now | ALX Oncology Holdings | $1.43 | 53.85% | $4 → $2.2 | Maintains | Buy | Get Alert | |
| 01/08/2025 | PFE | Buy Now | Pfizer | $25.43 | 14.04% | $31 → $29 | Maintains | Neutral | Get Alert | |
| 01/08/2025 | MRK | Buy Now | Merck & Co | $97.78 | 22.73% | $125 → $120 | Maintains | Buy | Get Alert | |
| 12/03/2024 | PTCT | Buy Now | PTC Therapeutics | $75.38 | -5.82% | $47 → $71 | Maintains | Buy | Get Alert | |
| 11/21/2024 | GILD | Buy Now | Gilead Sciences | $118.78 | -19.18% | $70 → $96 | Maintains | Neutral | Get Alert | |
| 11/05/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | 28.8% | $562 → $586 | Maintains | Buy | Get Alert | |
| 11/01/2024 | MRK | Buy Now | Merck & Co | $97.78 | 27.84% | $136 → $125 | Maintains | Buy | Get Alert | |
| 10/31/2024 | AMGN | Buy Now | Amgen | $326.54 | -0.17% | $335 → $326 | Maintains | Neutral | Get Alert | |
| 10/17/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | 23.53% | $477 → $562 | Maintains | Buy | Get Alert | |
| 10/09/2024 | MRK | Buy Now | Merck & Co | $97.78 | 39.09% | $142 → $136 | Maintains | Buy | Get Alert | |
| 10/03/2024 | BIIB | Buy Now | Biogen | $171.50 | 17.78% | $234 → $202 | Maintains | Neutral | Get Alert | |
| 08/26/2024 | PTCT | Buy Now | PTC Therapeutics | $75.38 | -37.65% | → $47 | Upgrade | Neutral → Buy | Get Alert | |
| 08/16/2024 | ALXO | Buy Now | ALX Oncology Holdings | $1.43 | 179.72% | $25 → $4 | Maintains | Buy | Get Alert | |
| 08/15/2024 | ABOS | Buy Now | Acumen Pharmaceuticals | $2.03 | 195.57% | $14 → $6 | Maintains | Buy | Get Alert | |
| 08/13/2024 | IMVT | Buy Now | Immunovant | $26.87 | 52.59% | $42 → $41 | Maintains | Buy | Get Alert | |
| 08/09/2024 | BTAI | Buy Now | BioXcel Therapeutics | $1.88 | -46.81% | $3.5 → $1 | Maintains | Neutral | Get Alert | |
| 07/31/2024 | MRK | Buy Now | Merck & Co | $97.78 | 45.22% | $148 → $142 | Maintains | Buy | Get Alert | |
| 07/31/2024 | PFE | Buy Now | Pfizer | $25.43 | 21.9% | $30 → $31 | Maintains | Neutral | Get Alert | |
| 07/12/2024 | AMGN | Buy Now | Amgen | $326.54 | 3.2% | $307 → $337 | Maintains | Neutral | Get Alert | |
| 07/12/2024 | PFE | Buy Now | Pfizer | $25.43 | 17.97% | $28 → $30 | Maintains | Neutral | Get Alert | |
| 05/03/2024 | AMGN | Buy Now | Amgen | $326.54 | -5.98% | $284 → $307 | Maintains | Neutral | Get Alert | |
| 04/17/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $746.36 | 47.25% | $1090 → $1099 | Maintains | Buy | Get Alert | |
| 04/17/2024 | AMGN | Buy Now | Amgen | $326.54 | -13.03% | $314 → $284 | Maintains | Neutral | Get Alert | |
| 04/17/2024 | BIIB | Buy Now | Biogen | $171.50 | 24.78% | $250 → $214 | Maintains | Neutral | Get Alert | |
| 04/17/2024 | GILD | Buy Now | Gilead Sciences | $118.78 | -36.86% | $81 → $75 | Maintains | Neutral | Get Alert | |
| 04/17/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | 2.43% | $498 → $466 | Maintains | Buy | Get Alert | |
| 03/31/2024 | ABOS | Buy Now | Acumen Pharmaceuticals | $2.03 | 589.66% | $15 → $14 | Maintains | Buy | Get Alert | |
| 03/28/2024 | ENGN | Buy Now | enGene Holdings | $8.38 | 341.53% | → $37 | Initiates | → Buy | Get Alert | |
| 03/01/2024 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.48 | 1451.72% | $56 → $54 | Maintains | Buy | Get Alert | |
| 03/01/2024 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 649.55% | $164 → $167 | Maintains | Buy | Get Alert | |
| 02/21/2024 | BTAI | Buy Now | BioXcel Therapeutics | $1.88 | 112.77% | $9 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 02/16/2024 | BIIB | Buy Now | Biogen | $171.50 | 45.77% | $276 → $250 | Maintains | Neutral | Get Alert | |
| 02/02/2024 | MRK | Buy Now | Merck & Co | $97.78 | 51.36% | $135 → $148 | Maintains | Buy | Get Alert | |
| 01/31/2024 | PFE | Buy Now | Pfizer | $25.43 | 10.11% | $29 → $28 | Maintains | Neutral | Get Alert | |
| 01/29/2024 | AMGN | Buy Now | Amgen | $326.54 | -3.84% | $315 → $314 | Maintains | Neutral | Get Alert | |
| 01/25/2024 | BIIB | Buy Now | Biogen | $171.50 | 60.93% | $311 → $276 | Downgrade | Buy → Neutral | Get Alert | |
| 01/24/2024 | BIIB | Buy Now | Biogen | $171.50 | 60.93% | → $276 | Downgrade | Buy → Neutral | Get Alert | |
| 01/17/2024 | PFE | Buy Now | Pfizer | $25.43 | 14.04% | $27 → $29 | Maintains | Neutral | Get Alert | |
| 12/14/2023 | PFE | Buy Now | Pfizer | $25.43 | 6.17% | $34 → $27 | Maintains | Neutral | Get Alert | |
| 12/01/2023 | IMVT | Buy Now | Immunovant | $26.87 | 108.41% | $55 → $56 | Maintains | Buy | Get Alert | |
| 11/02/2023 | AMGN | Buy Now | Amgen | $326.54 | -17.93% | $272 → $268 | Maintains | Neutral | Get Alert | |
| 10/20/2023 | PFE | Buy Now | Pfizer | $25.43 | 33.7% | $36 → $34 | Assumes | Neutral → Neutral | Get Alert | |
| 10/13/2023 | IMVT | Buy Now | Immunovant | $26.87 | 104.69% | $18 → $55 | Upgrade | Neutral → Buy | Get Alert | |
| 10/04/2023 | ALXO | Buy Now | ALX Oncology Holdings | $1.43 | 1788.11% | $29 → $27 | Maintains | Buy | Get Alert | |
| 07/24/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -6.8% | $399 → $424 | Maintains | Buy | Get Alert | |
| 05/15/2023 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 676.48% | $160 → $173 | Maintains | Buy | Get Alert | |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -12.3% | $375 → $399 | Maintains | Buy | Get Alert | |
| 03/15/2023 | ALXO | Buy Now | ALX Oncology Holdings | $1.43 | 1927.97% | $31 → $29 | Maintains | Buy | Get Alert | |
| 02/16/2023 | BIIB | Buy Now | Biogen | $171.50 | 98.25% | $337 → $340 | Maintains | Buy | Get Alert | |
| 02/08/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -17.58% | $373 → $375 | Maintains | Buy | Get Alert | |
| 01/30/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -18.01% | $342 → $373 | Maintains | Buy | Get Alert | |
| 01/26/2023 | PFE | Buy Now | Pfizer | $25.43 | 84.82% | $55 → $47 | Downgrade | Buy → Neutral | Get Alert | |
| 12/16/2022 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 609.16% | $100 → $158 | Upgrade | Neutral → Buy | Get Alert | |
| 12/15/2022 | LLY | Buy Now | Eli Lilly | $1.05K | -60.15% | $428 → $420 | Maintains | Buy | Get Alert | |
| 12/08/2022 | OMER | Buy Now | Omeros | $8.79 | -77.25% | $12 → $2 | Downgrade | Buy → Neutral | Get Alert | |
| 10/21/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -25.93% | $335 → $337 | Maintains | Buy | Get Alert | |
| 10/18/2022 | PROK | Buy Now | ProKidney | $2.23 | 707.17% | → $18 | Initiates | → Buy | Get Alert | |
| 10/06/2022 | BIIB | Buy Now | Biogen | $171.50 | 80.17% | $238 → $309 | Maintains | Buy | Get Alert | |
| 09/27/2022 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.48 | 1681.61% | $68 → $62 | Maintains | Buy | Get Alert | |
| 09/26/2022 | IMVT | Buy Now | Immunovant | $26.87 | -81.39% | $7 → $5 | Downgrade | Buy → Neutral | Get Alert | |
| 08/01/2022 | ABBV | Buy Now | AbbVie | $223.67 | -34.73% | $154 → $146 | Maintains | Neutral | Get Alert | |
| 07/28/2022 | BMY | Buy Now | Bristol-Myers Squibb | $54.37 | 37.94% | $73 → $75 | Maintains | Neutral | Get Alert | |
| 07/18/2022 | MRK | Buy Now | Merck & Co | $97.78 | 0.23% | $76 → $98 | Maintains | Neutral | Get Alert | |
| 04/27/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -29.22% | $325 → $322 | Maintains | Buy | Get Alert | |
| 04/18/2022 | CCCC | Buy Now | C4 Therapeutics | $2.29 | 1035.37% | $64 → $26 | Maintains | Buy | Get Alert | |
| 04/13/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -28.57% | $258 → $325 | Maintains | Buy | Get Alert | |
| 02/28/2022 | ABBV | Buy Now | AbbVie | $223.67 | -34.28% | $129 → $147 | Downgrade | Buy → Neutral | Get Alert | |
| 02/16/2022 | BTAI | Buy Now | BioXcel Therapeutics | $1.88 | 1229.79% | $88 → $25 | Maintains | Buy | Get Alert | |
| 12/13/2021 | MRK | Buy Now | Merck & Co | $97.78 | -22.27% | $98 → $76 | Downgrade | Buy → Neutral | Get Alert | |
| 12/13/2021 | PFE | Buy Now | Pfizer | $25.43 | 135.94% | $52 → $60 | Upgrade | Neutral → Buy | Get Alert | |
| 09/16/2021 | BIIB | Buy Now | Biogen | $171.50 | 157.73% | $475 → $442 | Maintains | Buy | Get Alert | |
| 08/23/2021 | CADL | Buy Now | Candel Therapeutics | $5.78 | 55.71% | → $9 | Initiates | → Buy | Get Alert | |
| 07/26/2021 | ABOS | Buy Now | Acumen Pharmaceuticals | $2.03 | 1230.05% | → $27 | Initiates | → Buy | Get Alert | |
| 06/10/2021 | BIIB | Buy Now | Biogen | $171.50 | 169.97% | → $463 | Upgrade | Neutral → Buy | Get Alert | |
| 05/12/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -38.68% | $278 → $279 | Maintains | Buy | Get Alert | |
| 04/06/2021 | ALXO | Buy Now | ALX Oncology Holdings | $1.43 | 6613.29% | → $96 | Initiates | → Buy | Get Alert | |
| 02/01/2021 | OMER | Buy Now | Omeros | $8.79 | 184.41% | → $25 | Initiates | → Buy | Get Alert | |
| 02/01/2021 | BTAI | Buy Now | BioXcel Therapeutics | $1.88 | 5165.96% | → $99 | Initiates | → Buy | Get Alert | |
| 02/01/2021 | MTEM | Buy Now | Molecular Templates | — | — | → $13 | Initiates | → Neutral | Get Alert | |
| 01/11/2021 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 11/20/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -36.7% | $287 → $288 | Maintains | Buy | Get Alert | |
| 10/28/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $454.96 | -36.92% | → $287 | Initiates | → Buy | Get Alert | |
| 10/28/2020 | SRPT | Buy Now | Sarepta Therapeutics | $22.28 | 851.53% | → $212 | Initiates | → Buy | Get Alert | |
| 10/28/2020 | PTCT | Buy Now | PTC Therapeutics | $75.38 | -27.04% | → $55 | Initiates | → Neutral | Get Alert | |
| 10/28/2020 | IMVT | Buy Now | Immunovant | $26.87 | 127.02% | → $61 | Initiates | → Buy | Get Alert | |
| 10/28/2020 | GILD | Buy Now | Gilead Sciences | $118.78 | -48.64% | → $61 | Initiates | → Neutral | Get Alert | |
| 10/28/2020 | BIIB | Buy Now | Biogen | $171.50 | 56.27% | → $268 | Initiates | → Neutral | Get Alert | |
| 10/28/2020 | AMGN | Buy Now | Amgen | $326.54 | -28.95% | → $232 | Initiates | → Neutral | Get Alert | |
| 07/29/2020 | PFE | Buy Now | Pfizer | $25.43 | 53.36% | $37 → $39 | Maintains | Neutral | Get Alert | |
| 01/22/2020 | AMGN | Buy Now | Amgen | $326.54 | -27.11% | $194 → $238 | Maintains | Neutral | Get Alert | |
| 04/29/2019 | MTEM | Buy Now | Molecular Templates | — | — | → $12 | Initiates | → Buy | Get Alert | |
| 01/23/2019 | PFE | Buy Now | Pfizer | $25.43 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 04/02/2018 | BTAI | Buy Now | BioXcel Therapeutics | $1.88 | 857.45% | → $18 | Initiates | → Buy | Get Alert | |
| 01/30/2013 | PFE | Buy Now | Pfizer | $25.43 | 21.9% | $29 → $31 | Maintains | Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved